Online citations, reference lists, and bibliographies.
← Back to Search

Effect Of Endotoxin And Cytokines On Lipoprotein Lipase Activity In Mice.

K. R. Feingold, M. Marshall, R. Gulli, A. Moser, C. Grunfeld
Published 1994 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Endotoxin (lipopolysaccharide [LPS]) stimulates the production of cytokines, which mediate many of the metabolic effects associated with infection. In LPS-sensitive C57B1/6 mice, LPS doses as low as 0.01 micrograms per mouse decreased adipose tissue lipoprotein lipase (LPL) activity by greater than 50%. In LPS-resistant C3H/HeJ mice, which do not produce cytokines in response to LPS, doses of LPS as high as 10 micrograms per mouse did not affect LPL activity in adipose tissue. In muscle of C57Bl/6 mice, LPL activity was decreased by 27% after 10 micrograms of LPS, whereas in C3H/HeJ mice there was no effect. These results indicate that the LPS-induced decrease in both adipose and muscle LPL activity is mediated by cytokines. Tumor necrosis factor (TNF), interleukin (IL)-1, leukemia-inhibiting factor (LIF), interferon alfa, and interferon gamma all decreased adipose tissue LPL activity in intact mice. In skeletal and cardiac muscle, only IL-1 and interferon gamma decreased LPL activity, whereas TNF, LIF, and interferon alfa had no effect. Inhibition of TNF activity blocked the increase in serum triglycerides that is characteristically observed after LPS but did not affect the ability of LPS to decrease adipose tissue LPL activity. Inhibition of IL-1 activity with IL-1 receptor antagonist partially inhibited the increase in serum triglycerides; however, the ability of LPS to decrease LPL activity in either adipose or muscle tissue was not affected. These data indicate that although TNF and IL-1 play a role in mediating the increase in serum triglyceride levels, these cytokines do not play a crucial role in the inhibition of either adipose or muscle LPL activity.(ABSTRACT TRUNCATED AT 250 WORDS)
This paper references
Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice.
R. A. Memon (1993)
Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat.
S. Lanza-Jacoby (1992)
Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance.
K. R. Feingold (1992)
Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo.
K. Feingold (1987)
Characterization of interleukin-11 receptor and protein tyrosine phosphorylation induced by interleukin-11 in mouse 3T3-L1 cells.
T. Yin (1992)
Decreased Myocardial Extracellular and Muscle Lipoprotein Lipase Activities in Endotoxin-Treated Rats
G. Bagby (1981)
Multiple biological activities of human recombinant interleukin 1.
C. Dinarello (1986)
Hypertriglyceridemia and its relation to tissue lipoprotein lipase activity in endotoxemic, Escherichia coli bacteremic, and polymicrobial septic rats.
R. A. Scholl (1984)
Tissue distribution of C14 after the intravenous injection of labeled chylomicrons and unesterified fatty acids in the rat.
J. H. Bragdon (1958)
Studies of endotoxin-induced decrease in lipoprotein lipase activity
M. Kawakami (1981)
Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo.
H. Semb (1987)
Effect of endotoxin and cytokines on lipoprotein lipase activity in mice
K Feingold
Lipoprotein lipase activity in at heart and adipose tissue during endotoxin shock
M Kawakami
Mechanism of the hypertriglyceridemia induced by tumor necrosis factor administration to rats.
T. Chajek-Shaul (1989)
Infection with Diplococcus pneumoniae and Salmonella typhimurium in monkeys: changes in plasma lipids and lipoproteins.
R. Fiser (1972)
Specific molecular activities of recombinant and hybrid leukocyte interferons.
E. Rehberg (1982)
Arterioscler Thromb Vasc Biol
Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin 1.
S. Price (1986)
Multiple cytokines stimulate hepatic lipid synthesis in vivo.
K. Feingold (1989)
Effect of Interferon on Plasma Lipoproteins and on the Activity of Postheparin Plasma Lipases
C. Ehnholm (1982)
Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.
J. S. Patton (1986)
Significance of lipoprotein lipase in rat skeletal muscle.
M. Tan (1977)
Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat.
C. Grunfeld (1989)
The effect of interleukin-1 on lipid metabolism in the rat: similarities and differences from tumor necrosis factor. Arteriosclerosis
KR Feingold (1994)
Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor--the primary regulatory role of the hormone in 3T3-L1 adipocytes.
S. Price (1986)
Effect of interleukin-1 alpha on lipoprotein lipids in cynomolgus monkeys: comparison to tumor necrosis factor.
W. H. Ettinger (1992)
Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level.
I. Gouni (1993)
Interleukin-1 and lipid metabolism in the rat.
J. Argilés (1989)
Tissue distribution of "C after the intravenous injection of labeled chylomicrons and unesterified fatty acid in the rat
JH Bragdon (1958)
American Heart Association Arteriosclerosis, Thrombosis, and Vascular Biology
Greenville Avenue (1994)
Serum lipids in infection.
J. Gallin (1969)
Triacylglycerol kinetics in endotoxic rats with suppressed lipoprotein lipase activity.
G. Bagby (1987)
Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients
R. Kurzrock (1986)
The significance of lipoprotein lipase in rat skeletal muscles.
M. Tan (1977)
Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia.
A. Greenberg (1992)
Effect of interleukin-1 on lipid metabolism in the rat. Similarities to and differences from tumor necrosis factor.
K. R. Feingold (1991)
Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice.
D. Metcalf (1990)
Role for monokines in the metabolic effects of endotoxin. Interferon-gamma restores responsiveness of C3H/HeJ mice in vivo.
S. Adi (1992)
Tumor necrosis factor stimulates hepatic lipid synthesis and secretion.
K. Feingold (1989)
Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells.
B. Beutler (1985)
Hypertriglyceridemia produced by endotoxin: role of impaired triglyceride disposal mechanisms.
R. Kaufmann (1976)
Interieukin-1 and lipid metabolism in the rat The significance of lipoprotein lipase in rat skeletal muscles
Jm Argiles (1977)
Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes.
S. Burchett (1988)
Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia.
M. Mori (1989)
Lipoprotein lipase and uptake of chylomicron triglyceride by skeletal muscle of rats.
C. Linder (1976)
Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression.
T. Ulich (1990)
Macrophage sensitivity to endotoxin: genetic control by a single codominant gene.
D. Rosenstreich (1978)
Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells
B. Beutler (1985)
Lipoprotein lipase activity in rat heart and adipose tissue during endotoxic shock.
G. Bagby (1980)

This paper is referenced by
Lipoprotein lipase: structure, function, regulation, and role in disease
J. R. Mead (2002)
3. Obesity and Dyslipidemia.
Shinichi Oikawa (2011)
Endothelial lipase is associated with inflammation in humans Published, JLR Papers in Press, September 15, 2006.
M. Paradis (2006)
Effects of anti-TNF therapy on glucose metabolism in patients with ankylosing spondylitis, psoriatic arthritis or juvenile idiopathic arthritis.
Bárbara Santos Pires da Silva (2010)
Sepsis Immunometabolism: From Defining Sepsis to Understanding How Energy Production Affects Immune Response
Ioannis Koutroulis (2019)
Obesity and dyslipidemia in patients with psoriasis
Chaoyang Miao (2019)
Endothelial lipase and the metabolic syndrome
B. Lamarche (2007)
Effect of scopoletin on lipoprotein lipase activity in 3T3-L1 adipocytes.
Jeong-yeh Yang (2007)
Ameliorative Effect of Allopurinol on Vascular Complications of Insulin Resistance
Hany M El-Bassossy (2015)
Endotoxin , TNF , and ILI decrease cholesterol 7 a-hydroxylase mRNA levels and activity
Kenneth. (2002)
Interleukin-6 stimulates hepatic triglyceride secretion in rats.
K. Nonogaki (1995)
Lipoproteins in inflammation and sepsis. II. Clinical aspects
M. Wendel (2006)
Effect of pioglitazone on metabolic features in endotoxemia model in obese diabetic db/db mice
M. Sharma (2017)
Plasma Phospholipid Fatty Acid Profile is Altered in Both Septic and Non-Septic Critically Ill: A Correlation with Inflammatory Markers and Albumin
František Novák (2016)
Regulació nutricional i endocrina de la lipòlisi i la lipoproteïna lipasa en la truita irisada ("Oncorhynchus mykiss") i l'orada ("Sparus aurata")
Amaya Albalat Ribé (2005)
Low-Density Lipoprotein Triglycerides Associated With Low-Grade Systemic Inflammation, Adhesion Molecules, and Angiographic Coronary Artery Disease: The Ludwigshafen Risk and Cardiovascular Health Study
W. März (2004)
The effect of N-stearoylethanolamine on plasma lipid composition in rats with experimental insulin resistance.
O. V. Onopchenko (2015)
Relationship of Cardiorespiratory Fitness and Body Mass Index with the Incidence of Dyslipidemia among Japanese Women: A Cohort Study
Takahisa Ohta (2019)
Low-density lipoprotein particle diameter and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
T. Grammer (2015)
Review: The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity
H. Harris (2000)
Kupffer cell products and interleukin 1? directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes
Nerea Bartolomé (2008)
Inhibition of c-Jun-N-terminal Kinase Increases Cardiac Peroxisome Proliferator-activated Receptor α Expression and Fatty Acid Oxidation and Prevents Lipopolysaccharide-induced Heart Dysfunction*
Konstantinos Drosatos (2011)
Lipid testing in infectious diseases: possible role in diagnosis and prognosis
S. Filippas-Ntekouan (2017)
Peripheral tumor necrosis factor α regulation of adipose tissue metabolism and adipokine gene expression in neonatal pigs
Tim Ramsay (2012)
Mechanisms of fructose-induced hypertension
Trinh Xuan Tran (2009)
Rapid downregulation of adipose tissue lipoprotein lipase activity on food deprivation: evidence that TNF-alpha is involved.
G. Wu (2004)
J. A. V. Diepen (2013)
Marcadores inflamatórios de instabilidade da placa aterosclerótica coronária : caraterização e potencial utilização clínica
L. S. Carvalho (2012)
The association between psoriasis and dyslipidaemia: a systematic review
C. Ma (2013)
Psoriasis and comorbidities: links and risks
Catherine S. Ni (2014)
Responses of Adipose and Muscle Lipoprotein Lipase to Chronic Infection and Subsequent Acute Lipopolysaccharide Challenge
F. Picard (2002)
TNF‐α, a potent lipid metabolism regulator
Xiuping Chen (2009)
See more
Semantic Scholar Logo Some data provided by SemanticScholar